US legal appeal rejected in win for Novo Nordisk
![Photo: Novo Nordisk / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13877376.ece/ALTERNATES/schema-16_9/doc7kciz4hhnaonwz2jiji.jpg)
The 9th US Circuit Court of Appeals voted unanimously on Monday to reject an attempt to reopen a legal case against Novo Nordisk, reports Reuters. The case concerned its type 2 diabetes drug Victoza, which the plaintiff claimed could cause pancreatic cancer.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.